← Open Payments lookup

IGOR VOLKOV: Open Payments

NPI 1588810162 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,052 in 39 payments from 8 companies in 2025. Trend: 2023 $2,009 · 2024 $3,343 · 2025 $2,052

Food & beverage: $2,052
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.7$355
Neurocrine BioSciences, Inc.5$338
Alkermes, Inc.7$338
Janssen Pharmaceuticals, Inc6$278
Vanda Pharmaceuticals Inc.2$222
Teva Pharmaceuticals USA, Inc.4$191
Otsuka America Pharmaceutical, Inc.6$188
ABBVIE INC.2$142

Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, ARISTADA, FANAPT, UZEDY, VRAYLAR, ABILIFY MAINTENA.

Industry payments across DC — which companies pay providers there.